肌肉生长抑制素抑制治疗突破
在全行业数十年来释放肌肉生长抑制素抑制潜力的努力屡屡失败之后，Scholar Rock 带来了治疗性突破。
English original
After decades of failed industry-wide efforts to unlock the potential of myostatin inhibition, Scholar Rock has delivered a therapeutic breakthrough.
FDA批准新闻稿
D
David HallalScholar Rock · chief executive